X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (552) 552
female (539) 539
index medicus (284) 284
middle aged (284) 284
ovarian neoplasms - pathology (282) 282
oncology (245) 245
cystadenocarcinoma, serous - pathology (241) 241
ovarian cancer (236) 236
aged (235) 235
adult (207) 207
cancer (198) 198
ovarian neoplasms - immunology (197) 197
prognosis (159) 159
cystadenocarcinoma, serous - genetics (142) 142
pathology (136) 136
immunohistochemistry (133) 133
carcinoma (131) 131
cystadenocarcinoma, serous - metabolism (128) 128
ovarian neoplasms - genetics (128) 128
tumors (127) 127
neoplasm staging (122) 122
ovarian neoplasms - metabolism (120) 120
cystadenocarcinoma, serous - immunology (108) 108
aged, 80 and over (105) 105
expression (95) 95
chemotherapy (89) 89
cystadenocarcinoma - immunology (84) 84
ovarian carcinoma (73) 73
survival (73) 73
neoplasm grading (72) 72
analysis (69) 69
ovarian neoplasms - mortality (67) 67
gene expression (66) 66
cystadenocarcinoma, serous - drug therapy (65) 65
cystadenocarcinoma, serous - mortality (64) 64
immunoenzyme techniques (63) 63
ovarian neoplasms - drug therapy (63) 63
gene expression regulation, neoplastic (62) 62
animals (61) 61
cell line, tumor (56) 56
ovarian neoplasms - diagnosis (54) 54
research article (54) 54
obstetrics & gynecology (53) 53
biomarkers, tumor - metabolism (51) 51
mutation (51) 51
cell biology (50) 50
cystadenocarcinoma, serous - diagnosis (49) 49
follow-up studies (49) 49
medicine (49) 49
research (49) 49
antigens, neoplasm - analysis (48) 48
genetic aspects (48) 48
metastasis (48) 48
retrospective studies (48) 48
mice (46) 46
biomarkers (45) 45
biomarkers, tumor - analysis (42) 42
breast-cancer (42) 42
development and progression (42) 42
survival rate (42) 42
adenocarcinoma, mucinous - pathology (41) 41
diagnosis (41) 41
proteins (41) 41
adenocarcinoma, clear cell - pathology (40) 40
endometrial neoplasms - pathology (40) 40
immunology (40) 40
medical prognosis (40) 40
multidisciplinary sciences (40) 40
science (40) 40
endocrine system diseases (39) 39
male (39) 39
case-control studies (38) 38
tumor cells, cultured (38) 38
cancer research (37) 37
treatment outcome (36) 36
adenocarcinoma, mucinous - immunology (35) 35
carcinoma, ovarian epithelial (35) 35
adenocarcinoma (34) 34
cystadenocarcinoma - pathology (34) 34
kaplan-meier estimate (34) 34
reverse transcriptase polymerase chain reaction (34) 34
cells (33) 33
surgery (33) 33
apoptosis (32) 32
article (32) 32
ovarian neoplasms - blood (32) 32
ovarian neoplasms - therapy (32) 32
biomedicine (31) 31
patients (31) 31
young adult (31) 31
adenocarcinoma - immunology (30) 30
carcinoma, endometrioid - pathology (30) 30
care and treatment (30) 30
diagnosis, differential (30) 30
p53 (30) 30
biomarkers, tumor - genetics (29) 29
flow cytometry (29) 29
health aspects (29) 29
cell proliferation (28) 28
cystadenocarcinoma, serous - surgery (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (517) 517
Chinese (18) 18
Japanese (15) 15
Polish (4) 4
Bulgarian (1) 1
French (1) 1
German (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e80063
Ovarian cancer is an immune reactive malignancy with a complex immune suppressive network that blunts successful immune eradication. This suppressive... 
GYNECOLOGIC-ONCOLOGY-GROUP | NEU-TRANSGENIC MICE | PROGNOSTIC-FACTORS | REGULATORY CELLS | DENDRITIC CELLS | MULTIDISCIPLINARY SCIENCES | TRANSCRIPTION FACTOR FOXP3 | TUMOR | INDUCTION | AUTOIMMUNE-DISEASE | CARCINOMA | CD8-Positive T-Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Ovarian Neoplasms - mortality | CD4-Positive T-Lymphocytes - pathology | Cystadenocarcinoma, Serous - pathology | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Ovarian Neoplasms - genetics | Interleukin-2 Receptor alpha Subunit - genetics | Aged, 80 and over | Adult | Female | Cystadenocarcinoma, Serous - immunology | Interleukin-2 Receptor alpha Subunit - immunology | Gene Expression | Ovary - pathology | Ovary - immunology | Immunophenotyping | Survival Analysis | Cystadenocarcinoma, Serous - mortality | Lymphocyte Count | Aged | CD8-Positive T-Lymphocytes - immunology | Forkhead Transcription Factors | Ovarian Neoplasms - immunology | Transcription factors | Ovarian carcinoma | CD8 antigen | Effector cells | Cytotoxicity | Lymphocytes T | Malignancy | Clinical outcomes | Ovarian cancer | Immunology | Lymphocytes | Immunotherapy | CD25 antigen | Foxp3 protein | Cell survival | Immunoregulation | Histology | CD3 antigen | Patients | Survival | CD4 antigen | Studies | Chemotherapy | Medical prognosis | Immunofluorescence | Cancer | Tumors
Journal Article
Journal Article
Journal Article
Cell, ISSN 0092-8674, 08/2017, Volume 170, Issue 5, pp. 927 - 938.e20
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2017, Volume 23, Issue 24, pp. 7621 - 7632
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2017, Volume 23, Issue 1, pp. 250 - 262
Purpose: In high-grade serous ovarian cancer (HGSOC), higher densities of both B cells and the CD8(+) T-cell infiltrate were associated with a better... 
TUMOR-INFILTRATING LYMPHOCYTES | LUNG-CANCER | TERTIARY LYMPHOID STRUCTURES | CARCINOGENESIS | FC-GAMMA RECEPTORS | DENDRITIC CELLS | REGULATORY CELLS | ONCOLOGY | IMMUNOTHERAPY | MATURATION | CD8(+) T-CELLS | Immunohistochemistry | Dendritic Cells - immunology | Humans | Cystadenocarcinoma, Serous - metabolism | Cystadenocarcinoma, Serous - drug therapy | Neoplasm Metastasis | Neoplasm Grading | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Ovarian Neoplasms - metabolism | Proteomics - methods | Cystadenocarcinoma, Serous - immunology | Ovarian Neoplasms - drug therapy | B-Lymphocytes - metabolism | Dendritic Cells - metabolism | Antibody Formation - immunology | Cytokines - metabolism | Ovarian Neoplasms - diagnosis | Immunophenotyping | Proteome | B-Lymphocytes - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Biomarkers | Cell Line, Tumor | Immunologic Memory | Cystadenocarcinoma, Serous - diagnosis | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Ovarian Neoplasms - immunology | Lymphocyte receptors | Multiplexing | Flow cytometry | Ovarian carcinoma | Transcription | CD86 antigen | CD8 antigen | Cytotoxicity | Lymphocytes T | Metastasis | Metastases | Ovarian cancer | Cell activation | Quality | Localization | Antigen-antibody complexes | Immune system | Antigens | Immunological memory | Immune response | Cytokines | Stroma | T cell receptors | Cytometry | Chemotherapy | Lymphocytes B | Experimental design | Antigen-presenting cells | Antigen (tumor-associated) | Plasma cells | CD20 antigen | Antitumor activity | Dendritic structure | Chemokines | Cancer | Peritoneum
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2014, Volume 134, Issue 1, pp. 32 - 42
Ovarian cancer is typically accompanied by the occurrence of malignant ascites containing large number of macrophages. It has been suggested that these... 
ovarian carcinoma | CD163 | tumor‐associated macrophages | IL‐10 | IL‐6 | IL-10 | IL-6 | tumor-associated macrophages | MYELOID CELLS | INTERLEUKIN-6 | M2-POLARIZED MACROPHAGES | HUMAN MONOCYTES | CANCER | SCAVENGER RECEPTOR CD163 | ONCOLOGY | SERUM-LEVELS | IN-VIVO | PROGNOSTIC-SIGNIFICANCE | Antigens, CD - immunology | Cell Polarity | Oligonucleotide Array Sequence Analysis | Antigens, CD - biosynthesis | Humans | Cystadenocarcinoma, Serous - metabolism | Ovarian Neoplasms - pathology | Transcriptome | Cystadenocarcinoma, Serous - pathology | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Flow Cytometry | Ascites - immunology | Female | Ovarian Neoplasms - metabolism | Receptors, Cell Surface - biosynthesis | Cystadenocarcinoma, Serous - immunology | Antigens, Differentiation, Myelomonocytic - immunology | Macrophages - immunology | Cytokines - immunology | Antigens, Differentiation, Myelomonocytic - biosynthesis | Enzyme-Linked Immunosorbent Assay | Macrophages - pathology | Neoplasm Recurrence, Local - metabolism | Kaplan-Meier Estimate | Receptors, Cell Surface - immunology | Disease-Free Survival | Macrophages - metabolism | Phenotype | Cytokines - biosynthesis | Ovarian Neoplasms - immunology | Carcinoma | Cytokines | Analysis | Genetic aspects | Macrophages | Gene expression | Ascites | Ovarian cancer | Cancer | Genotype & phenotype | Cancer Cell Biology
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 145, Issue 3, pp. 436 - 445
Journal Article